Vitrolife AB
STO:VITR
Vitrolife AB
STO:VITR
Price:
182.1 SEK
-2.31%
Market Closed
Updated:
May 29, 2024
Vitrolife AB
Selling, General & Administrative
|
Vitrolife AB
Selling, General & Administrative Peer Comparison
Comparables:
BIOG B
HNSA
BONEX
SOBI
BIOA B
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vitrolife AB
STO:VITR
|
Selling, General & Administrative
-kr1.1B
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-20%
|
|
|
Biogaia AB
STO:BIOG B
|
Selling, General & Administrative
-kr398.7m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Hansa Biopharma AB
STO:HNSA
|
Selling, General & Administrative
-kr435m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-59%
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Selling, General & Administrative
-kr498.3m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Selling, General & Administrative
-kr6.9B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-27%
|
|
|
BioArctic AB
STO:BIOA B
|
Selling, General & Administrative
-kr200.3m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
See Also
What is Vitrolife AB's Selling, General & Administrative?
Selling, General & Administrative
-1.1B
SEK
-1.1B
SEK
Based on the financial report for Mar 31, 2024, Vitrolife AB's Selling, General & Administrative amounts to -1.1B SEK.
What is Vitrolife AB's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-20%
-20%
Over the last year, the Selling, General & Administrative growth was -1%. The average annual Selling, General & Administrative growth rates for Vitrolife AB have been -51% over the past three years , -29% over the past five years , and -20% over the past ten years .
You don't have any saved screeners yet
